Altered anandamide degradation in attention-deficit/hyperactivity disorder.
Centonze
D
D
Clinica Neurologica, Dipartimento di Neuroscienze, Università Tor Vergata, Via Montpellier 1, 00133 Rome, Italy. centonze@uniroma2.it
Bari
M
M
Di Michele
B
B
Rossi
S
S
Gasperi
V
V
Pasini
A
A
Battista
N
N
Bernardi
G
G
Curatolo
P
P
Maccarrone
M
M
D000293:Adolescent; D000581:Amidohydrolases / Q000032:analysis / Q000097:blood; D001095:Arachidonic Acids / Q000032:analysis / Q000378:metabolism*; D001289:Attention Deficit Disorder with Hyperactivity / Q000097:blood / Q000201:enzymology* / Q000503:physiopathology; D001921:Brain / Q000201:enzymology* / Q000503:physiopathology; D063385:Cannabinoid Receptor Modulators / Q000032:analysis / Q000378:metabolism*; D002648:Child; D015331:Cohort Studies; D004298:Dopamine / Q000378:metabolism*; D050483:Dopamine Plasma Membrane Transport Proteins / Q000378:metabolism; D015536:Down-Regulation / Q000502:physiology; D063388:Endocannabinoids; D006801:Humans; D008214:Lymphocytes / Q000378:metabolism; D008297:Male; D009434:Neural Pathways / Q000378:metabolism / Q000503:physiopathology; D010739:Phospholipase D / Q000032:analysis / Q000097:blood; D053284:Polyunsaturated Alkamides / Q000032:analysis / Q000378:metabolism*; D011237:Predictive Value of Tests; D000099252:Fatty Acid Amide Hydrolases
D000581:Amidohydrolases; D001095:Arachidonic Acids; D063385:Cannabinoid Receptor Modulators; D004298:Dopamine; D050483:Dopamine Plasma Membrane Transport Proteins; D063388:Endocannabinoids; D010739:Phospholipase D; D053284:Polyunsaturated Alkamides; D000099252:Fatty Acid Amide Hydrolases; C078814:anandamide